Health Care: Drugs

Teva Pharmaceutical Industries Ltd (TEVA: NYSE)

$54.08 -2.83 | -4.97%
02/11/16 - 04:00 PM ET
Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 3.04B 1.25B 1.91B 2.77B
Operating Gains/Losses 1.00M 18.00M -3.00M -207.00M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 710.00M 85.00M 936.00M 704.00M
(Increase) Decrease in Inventories 230.00M 399.00M -449.00M -410.00M
(Increase) Decrease In Other Current Assets -36.00M 106.00M -54.00M -240.00M
(Decrease) Increase In Payables -614.00M 378.00M -19.00M 543.00M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 512.00M 736.00M 1.23B 407.00M
Net Cash From Continuing Operations 5.13B 3.24B 4.57B 4.13B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 5.13B 3.24B 4.57B 4.13B
Sale of Property, Plant & Equipment 196.00M 187.00M 264.00M 279.00M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -929.00M -1.03B -1.10B -1.05B
Acquisitions -363.00M -39.00M 0.00 -6.56B
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -30.00M -104.00M -93.00M -49.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.45B -1.15B -1.13B -7.60B
Issuance of Debt 0.00 338.00M 1.24B 6.72B
Cash Used for Financing Activities
Issuance of Capital Stock 514.00M 91.00M 14.00M 71.00M
Repayment of Long-Term Debt -839.00M -3.13B -2.21B -1.56B
Repurchase of Capital Stock -500.00M -497.00M -1.16B -899.00M
Payment of Cash Dividends -1.16B -1.09B -855.00M -800.00M
Other Financing Charges, Net -394.00M 407.00M 1.30B -194.00M
Net Cash From Financing Activities -2.38B -3.88B -1.68B 3.34B
Effect of Exchange Rate Changes -114.00M -48.00M 23.00M -21.00M
Net Change in Cash & Cash Equivalents 1.19B -1.84B 1.78B -152.00M

Portfolios with TEVA

Latest TEVA Headlines from TheStreet

More Financial News for TEVA

Press Releases for TEVA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter